US Supreme Court to hear oral arguments in Medtronic v Boston Scientific

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

US Supreme Court to hear oral arguments in Medtronic v Boston Scientific

The US Supreme Court will hear oral arguments today in a case which may shed light on who has the burden of proof when a patent licensee is accused of infringing the patent.

In Medtronic v Boston Scientific, the court will consider whether a licensee challenging a declaratory judgment must demonstrate that its product does not infringe, or whether the patent holder must prove there was infringement.

The case concerns a device manufactured by Medtronic which treats heart failure, known as cardiac resynchronisation therapy (CRT). The patent is owned by Mirowski Family Ventures, which licensed it to another company called Guidant. In 1991, Medtronic sublicensed the patent to Eli Lilly, which had taken over from Guidant as the party-in-interest.

In 2007, Mirowski claimed several Medtronic products infringed the patents. Medtronic sued for a declaratory judgment of non-infringement.

In all other patent litigation, including other declaratory judgments, the burden of proving infringement is on the patent owner. But in September last year, the Federal Circuit ruled that Medtronic had the burden of proving it did not infringe, because it had brought the action for a declaratory judgment and because it was the licensee.

The Federal Circuit said that since the only remedy sought by Medtronic was having a court declare the products in question to be non-infringing, Medtronic should bear the burden of proving it is entitled to such relief.

“A contrary result would allow licensees to use MedImmune’s shield as a sword—haling licensors into court and forcing them to assert and prove what had already been resolved by license,” wrote Judge Richard Linn on behalf of the panel.

The decision overturned a ruling by the District Court for the District of Delaware, which upheld the validity of the patents but concluded that Medtronic did not infringe.

Medtronic appealed to the Supreme Court in March this year, and the court agreed to hear the case in May.

more from across site and SHARED ros bottom lb

More from across our site

The UK-India trade deal doesn’t mention legal services, showing India has again failed to agree on a move that could help foreign firms and local practitioners
Eva-Maria Strobel reveals some of the firm’s IP achievements and its approach to client relationships
Lateral hires at Thompson Hine and Pierson Ferdinand said they were inspired by fresh business opportunities and innovative strategies at their new firms
The launch of a new IP insurance product and INTA hiring a former USPTO commissioner were also among the top talking points this week
The firm explains how it secured a $170.6 million verdict against the government in a patent dispute surrounding airport technology, and why the case led to interest from other inventors
Developments of note included the court partially allowing a claim concerning confidentiality clubs and a decision involving technology used in football matches
The firm said adding capability in the French capital completes its coverage of all major patent litigation jurisdictions as it strives for UPC excellence
Marc Fenster explains how keeping the jury focused on the most relevant facts helped secure a $279m win for his client against Samsung
Clients are divided on what externally funded IP firms bring to the table, so those firms must prove why the benefits outweigh the downsides
Rahul Bhartiya, AI coordinator at the EUIPO, discusses the office’s strategy, collaboration with other IP offices, and getting rid of routine tasks
Gift this article